Illinois CancerCare
- Research works
- 107 ▼ 22% vs 2013–17
- Citations
- 2.9k 27.2 per fractional work
- Top-10% rate
- 19.4% record average 16.5%
- Open access
- 35% world 28%
Not ranked overall: Illinois CancerCare is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 3.6×. Every wedge is a field page.
- Economics, Econometrics and Finance 3.6×
- Biochemistry, Genetics and Molecular Biology 3.4×
- Medicine 3.4×
- Immunology and Microbiology 3.1×
- Pharmacology, Toxicology and Pharmaceutics 1.1×
- Nursing 0.9×
- Health Professions 0.5×
- Agricultural and Biological Sciences 0.2×
- Environmental Science 0.1×
- Social Sciences 0.1×
- Neuroscience 0.1×
- Psychology 0.1×
- Engineering 0.0×
- Computer Science 0.0×
- Business, Management and Accounting 0.0×
Which keywords describe research at Illinois CancerCare?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Clinical Trials, Prognostic Factors, Targeted Therapy, Immunotherapy, Quality of Life, Angiogenesis and Metastasis.
- Prostate Cancer
- Precision Medicine
- Pelvic Floor Dysfunction
- Clinical Guidelines
- Taxanes
- Chemotherapy-Induced Peripheral Neuropathy
- Urinary Incontinence
- Neurotoxicity
- Cancer Therapy
- PET Imaging
- Rituximab
- ALK Inhibitors
- Breast Cancer
- Treatment Guidelines
- Genomic Profiling
- Angiogenesis
- Immunotherapy
- Inflammation
- Prognostic Factors
- Quality of Life
- Chemotherapy
- Clinical Trials
- Targeted Therapy
- Epidemiology
- Cancer
- Metastasis
- Radiotherapy
- Tumor Microenvironment
- Clinical Practice Guidelines
- EGFR Mutations
- Metastatic Breast Cancer
- Surgical Treatment
- Molecular Subtypes
- Rehabilitation
- Cancer Progression
- Extracellular Matrix
- Cetuximab
- Lymphoma
- Pelvic Organ Prolapse
- Neoadjuvant Therapy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy11▲ 15×23 topics
- Quality of Life8▲ 5.5×14 topics
- Clinical Trials8▲ 12×13 topics
- Prognostic Factors8▲ 16×11 topics
- Targeted Therapy8▲ 33×5 topics
- Inflammation7▲ 3.0×35 topics
- Epidemiology7▲ 1.66×32 topics
- Immunotherapy7▲ 10×14 topics
- Cancer6▲ 4.0×32 topics
- Angiogenesis5▲ 12×10 topics
- Metastasis5▲ 13×11 topics
- Genomic Profiling5▲ 44×2 topics
- Radiotherapy4▲ 11×11 topics
- Treatment Guidelines4▲ 19×3 topics
- Tumor Microenvironment4▲ 11×7 topics
- Breast Cancer4▲ 14×10 topics
- Clinical Practice Guidelines4▲ 7.1×10 topics
- ALK Inhibitors4▲ 68×1 topic
- EGFR Mutations4▲ 68×1 topic
- Rituximab4▲ 22×2 topics
- Metastatic Breast Cancer4▲ 52×2 topics
- PET Imaging4▲ 15×4 topics
- Surgical Treatment4▲ 16×6 topics
- Cancer Therapy3▲ 4.5×11 topics
- Molecular Subtypes3▲ 32×2 topics
- Neurotoxicity3▲ 15×2 topics
- Rehabilitation3▲ 7.5×3 topics
- Urinary Incontinence3▲ 30×2 topics
- Cancer Progression3▲ 12×6 topics
- Chemotherapy-Induced Peripheral Neuropathy3▲ 53×1 topic
- Extracellular Matrix3▲ 11×3 topics
- Taxanes3▲ 53×1 topic
- Cetuximab3▲ 31×2 topics
- Clinical Guidelines3▲ 8.2×5 topics
- Lymphoma3▲ 17×4 topics
- Pelvic Floor Dysfunction3▲ 49×1 topic
- Pelvic Organ Prolapse3▲ 49×1 topic
- Precision Medicine3▲ 8.0×5 topics
- Neoadjuvant Therapy2▲ 10×5 topics
- Prostate Cancer2▲ 15×4 topics
Which research topics does Illinois CancerCare publish most on?
By volume in 2022–2025: Economic and Financial Impacts of Cancer, Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations and Health Systems, Economic Evaluations, Quality of Life.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 2 Chronic Lymphocytic Leukemia Research Genetics 0 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 5 Cancer-related cognitive impairment studies Pulmonary and Respiratory Medicine 0 works
- 6 Cancer survivorship and care Oncology 0 works
- 7 Lung Cancer Research Studies Oncology 0 works
- 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 9 Acute Myeloid Leukemia Research Hematology 0 works
- 10 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Illinois CancerCare's research output changed?
Output in 2018–2022 was 22% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Peoria
- National Center for Agricultural Utilization Research
- Bradley University
- Caterpillar (United States)
- Peoria campus of the University of Illinois System
- OSF Saint Francis Medical Center
- OSF HealthCare
- Peoria Hospital
- Bleeding & Clotting Disorders Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.